Differential signaling by type-I and type-III interferons in mucosa
Current Opinion in Immunology · 2024
DOI: 10.1016/j.coi.2023.102400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Immunology, 2024. Verfasst von Megan L Stanifer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: m.stanifer@u…. Hauptthemen laut MEDLINE: Interferon Lambda, Interferon Type I. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Florida, College of Medicine, University of Florida.
Abstract (Originalsprache)
Mucosal surfaces are barrier sites that protect the body from the outside environment. They have developed mechanisms to handle microbiota-associated triggers while remaining responsive to pathogens. Cells at mucosal surfaces rely on both the type-I and -III interferons (IFNs) as key cytokines to protect the epithelium itself and to prevent systemic spread of viral infections. Type-I and -III IFNs have been shown to use distinct receptors but similar JAK/STAT signaling cascades to elicit the induction of IFN-stimulated genes. These overlapping cascades led to the original hypothesis that both IFNs provided redundant functions at mucosal surfaces. However, accumulating evidence points toward a different model where each IFN provides a unique protective and homeostatic function as well as distinct antiviral protection to epithelial cells. This review will highlight recent work shedding light on the differences in how both type -I and -III IFNs induce receptor-mediated signaling to protect mucosal surfaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: m.stanifer@ufl.edu.
- Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: s.boulant@ufl.edu.
Förderung
- University of Florida
- College of Medicine, University of Florida
Zitieren
APA
Stanifer, M. L., & Boulant, S. (2024). Differential signaling by type-I and type-III interferons in mucosa. Current Opinion in Immunology. https://doi.org/10.1016/j.coi.2023.102400
Vancouver
Stanifer ML, Boulant S. Differential signaling by type-I and type-III interferons in mucosa. Current Opinion in Immunology. 2024. doi:10.1016/j.coi.2023.102400
BibTeX
@article{Stanifer2024,
author = {Stanifer, Megan L and Boulant, Steeve},
title = {Differential signaling by type-I and type-III interferons in mucosa},
journal = {Current Opinion in Immunology},
year = {2024},
doi = {10.1016/j.coi.2023.102400}
}
EUVIMED